Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Ellenberg

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of General Virology|September 18, 2007
Superinfection exclusion in BHK-21 cells persistently infected with Junín virusPaula Ellenberg, Florencia N Linero, Luis A Scolaro
Immunology and Cell Biology|November 16, 2011
HDAC inhibitors in HIVFiona Wightman, Paula Ellenberg, Melissa Churchill, et al.
Journal of Virology|November 8, 2013
Intracellular dynamics of HIV infectionJanka Petravic, Paula Ellenberg, Ming-Liang Chan, et al.
Retrovirology|July 16, 2024
High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central AustraliaAshley Hirons, David Yurick, Natasha Jansz, et al.
Journal of Virology|December 28, 2013
Identifying recombination hot spots in the HIV-1 genomeRedmond P Smyth, Timothy E Schlub, Andrew J Grimm, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
Plos Pathogens|October 10, 2025
Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptaseMuriel Aldunate, David Tyssen, Adam Johnson, et al.
Plos One|November 20, 2014
Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapyHao K Lu, Lachlan R Gray, Fiona Wightman, et al.
AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.
Retrovirology|August 9, 2020
Longitudinal analysis of subtype C envelope tropism for memory CD4<sup>+</sup> T cell subsets over the first 3 years of untreated HIV-1 infectionMatthew J Gartner, Paul R Gorry, Carolin Tumpach, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of General Virology|September 18, 2007
Superinfection exclusion in BHK-21 cells persistently infected with Junín virusPaula Ellenberg, Florencia N Linero, Luis A Scolaro
Immunology and Cell Biology|November 16, 2011
HDAC inhibitors in HIVFiona Wightman, Paula Ellenberg, Melissa Churchill, et al.
Journal of Virology|November 8, 2013
Intracellular dynamics of HIV infectionJanka Petravic, Paula Ellenberg, Ming-Liang Chan, et al.
Retrovirology|July 16, 2024
High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central AustraliaAshley Hirons, David Yurick, Natasha Jansz, et al.
Journal of Virology|December 28, 2013
Identifying recombination hot spots in the HIV-1 genomeRedmond P Smyth, Timothy E Schlub, Andrew J Grimm, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
Plos Pathogens|October 10, 2025
Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptaseMuriel Aldunate, David Tyssen, Adam Johnson, et al.
Plos One|November 20, 2014
Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapyHao K Lu, Lachlan R Gray, Fiona Wightman, et al.
AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.
Retrovirology|August 9, 2020
Longitudinal analysis of subtype C envelope tropism for memory CD4<sup>+</sup> T cell subsets over the first 3 years of untreated HIV-1 infectionMatthew J Gartner, Paul R Gorry, Carolin Tumpach, et al.
Pageof 2